Market Cap 1.32B
Revenue (ttm) 79.95M
Net Income (ttm) -4.60M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 56.41
Profit Margin -5.75%
Debt to Equity Ratio 1.00
Volume 604,300
Avg Vol 468,110
Day's Range N/A - N/A
Shares Out 27.39M
Stochastic %K 95%
Beta 0.86
Analysts Strong Sell
Price Target $46.70

Company Profile

Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyros...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 847 787 7361
Address:
21925 W. Field Parkway, Suite 235, Deer Park, United States
oaksapollo
oaksapollo Jul. 30 at 3:30 PM
$ETON what happened to $50?! I saw it briefly yesterday. Honestly, if it goes over $50 and stays there, I may be cashing in. My cost is $3.85. $50 is just too good to pass up.
2 · Reply
Tom2772
Tom2772 Jul. 30 at 7:52 AM
$GOSS $ETON $OTLK Thanks for sharing your thoughts. Just a quick fact check: Opaleye's 5.1% stake (13G) and the planned NDA submission are confirmed. The reverse split, $175M raise, 500M new shares, 30% dilution and a November exit are all speculation at this point, not company guidance.
0 · Reply
prat1703
prat1703 Jul. 30 at 7:19 AM
$GOSS : Few things I’d say, 1: GOSS has been noticed by the momentum pump and dump buyers (they’ll be gone by next week likely) 2. GOSS getting new investors, Opaleye opened a 5% position on July 22 (13 GA filing), they’re good ones, bought $ETON at $5 and kept it on their portfolio, and more importantly, are HODLERS, can see them holding through PFUFA easily 3. GOSS, we, everyone needs the RS (needs to be on NASDAQ Global Select), but more importantly, Options market open up as bid price >$2 (1:20 maybe my bet so $4) 4. Dilution is real and will happen, let’s say they add $175M to balance sheet and issue 500M more shares, then we all lose 30% easy, but here it’s important to keep some cash and buy more 5. November is the earliest possible exit horizon, if acceptance to file goes well, key de risking event will be gone and it’ll be the $OTLK moment, unless you’re aiming to hold for 12 months
3 · Reply
CharlieeMungerTWITS
CharlieeMungerTWITS Jul. 29 at 11:19 PM
$CORT geniuses whomever held this from $35.00 Same geniuses at $ETON Now do we have geniuses at $CELC after fda approval?
0 · Reply
pickens1
pickens1 Jul. 29 at 7:07 PM
0 · Reply
CharlieeMungerTWITS
CharlieeMungerTWITS Jul. 29 at 1:58 PM
0 · Reply
maniha
maniha Jul. 29 at 12:22 AM
$ETON it’s almost time…
0 · Reply
topstockalerts
topstockalerts Jul. 28 at 11:15 PM
$ETON that was a sharp rejection of lower prices.
0 · Reply
ScanStock
ScanStock Jul. 28 at 11:01 PM
Big bulls calling you APUS right now for a run! Looks like they might be right, Loads of bulls moving to APUS now! The next low float stock to squeeze north Look APUS starting to run with fresh news <-- $JBLU $FMAO $ETON $LPSN <<< -
0 · Reply
JFais
JFais Jul. 28 at 9:26 PM
What ticker comes to mind that you could've handled better? I owned $ETON at $3 to $4, but failed to hold patiently (now $47)
3 · Reply
Latest News on ETON
Eton Pharmaceuticals initiated with a Buy at Canaccord

2026-07-17T09:40:14.000Z - 13 days ago

Eton Pharmaceuticals initiated with a Buy at Canaccord


Eton Pharmaceuticals initiated with a Buy at Canaccord

2026-07-16T20:16:10.000Z - 14 days ago

Eton Pharmaceuticals initiated with a Buy at Canaccord


Eton Pharmaceuticals Earnings Call Transcript: Q1 2026

May 14, 2026, 4:30 PM EDT - 2 months ago

Eton Pharmaceuticals Earnings Call Transcript: Q1 2026


Eton Pharmaceuticals Earnings release: Q1 2026

May 14, 2026, 4:30 PM EDT - 2 months ago

Eton Pharmaceuticals Earnings release: Q1 2026


Eton Pharmaceuticals Quarterly report: Q1 2026

May 14, 2026, 4:30 PM EDT - 2 months ago

Eton Pharmaceuticals Quarterly report: Q1 2026


Eton Pharmaceuticals announces relaunch of Hemangeol

2026-05-01T11:06:48.000Z - 3 months ago

Eton Pharmaceuticals announces relaunch of Hemangeol


Eton Pharmaceuticals Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 3 months ago

Eton Pharmaceuticals Proxy statement: Proxy filing


Eton Pharmaceuticals appoints Judith Matthews as CFO

2026-04-16T11:31:33.000Z - 3 months ago

Eton Pharmaceuticals appoints Judith Matthews as CFO


Eton Pharmaceuticals Announces CFO Succession Plan

Apr 16, 2026, 6:50 AM EDT - 3 months ago

Eton Pharmaceuticals Announces CFO Succession Plan


Eton Pharmaceuticals Earnings Call Transcript: Q4 2025

Mar 19, 2026, 4:30 PM EDT - 4 months ago

Eton Pharmaceuticals Earnings Call Transcript: Q4 2025


Eton Pharmaceuticals Annual report: Q4 2025

Mar 19, 2026, 4:30 PM EDT - 4 months ago

Eton Pharmaceuticals Annual report: Q4 2025


Eton Pharmaceuticals Earnings release: Q4 2025

Mar 19, 2026, 4:30 PM EDT - 4 months ago

Eton Pharmaceuticals Earnings release: Q4 2025


Eton Pharmaceuticals reports Q4 EPS 5c vs. (2c) last year

2026-03-19T20:17:23.000Z - 4 months ago

Eton Pharmaceuticals reports Q4 EPS 5c vs. (2c) last year


Eton Pharmaceuticals trading resumes

2026-02-25T19:15:17.000Z - 5 months ago

Eton Pharmaceuticals trading resumes


US FDA approves Eton Pharma's hormonal disorder drug

Feb 25, 2026, 1:51 PM EST - 5 months ago

US FDA approves Eton Pharma's hormonal disorder drug


Eton Pharmaceuticals Earnings Call Transcript: Q3 2025

Nov 6, 2025, 4:30 PM EST - 9 months ago

Eton Pharmaceuticals Earnings Call Transcript: Q3 2025


Eton Pharmaceuticals Quarterly report: Q3 2025

Nov 6, 2025, 4:30 PM EST - 9 months ago

Eton Pharmaceuticals Quarterly report: Q3 2025


Eton Pharmaceuticals Earnings release: Q3 2025

Nov 6, 2025, 4:30 PM EST - 9 months ago

Eton Pharmaceuticals Earnings release: Q3 2025


Eton Pharmaceuticals Earnings Call Transcript: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

Eton Pharmaceuticals Earnings Call Transcript: Q2 2025


Eton Pharmaceuticals Quarterly report: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

Eton Pharmaceuticals Quarterly report: Q2 2025


Eton Pharmaceuticals Earnings release: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

Eton Pharmaceuticals Earnings release: Q2 2025


Eton Pharmaceuticals Slides: Corporate Presentation

May 19, 2025, 7:00 AM EDT - 1 year ago

Eton Pharmaceuticals Slides: Corporate Presentation


Eton Pharmaceuticals Earnings Call Transcript: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

Eton Pharmaceuticals Earnings Call Transcript: Q1 2025


Eton Pharmaceuticals Quarterly report: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

Eton Pharmaceuticals Quarterly report: Q1 2025


Eton Pharmaceuticals Earnings release: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

Eton Pharmaceuticals Earnings release: Q1 2025


Eton Pharmaceuticals Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Eton Pharmaceuticals Proxy statement: Proxy Filing


Eton Pharmaceuticals Slides: Investor Presentation

Apr 4, 2025, 7:00 AM EDT - 1 year ago

Eton Pharmaceuticals Slides: Investor Presentation


Eton Pharmaceuticals Transcript: Investor Day 2025

Mar 18, 2025, 10:00 AM EDT - 1 year ago

Eton Pharmaceuticals Transcript: Investor Day 2025


Eton Pharmaceuticals Earnings release: Q4 2024

Mar 18, 2025, 10:00 AM EDT - 1 year ago

Eton Pharmaceuticals Earnings release: Q4 2024


Eton Pharmaceuticals Annual report: Q4 2024

Mar 18, 2025, 10:00 AM EDT - 1 year ago

Eton Pharmaceuticals Annual report: Q4 2024


Eton Pharmaceuticals Slides: FY 2025

Mar 18, 2025, 10:00 AM EDT - 1 year ago

Eton Pharmaceuticals Slides: FY 2025


Eton Pharmaceuticals Earnings Call Transcript: Q3 2024

Nov 12, 2024, 4:30 PM EST - 1 year ago

Eton Pharmaceuticals Earnings Call Transcript: Q3 2024


Eton Pharmaceuticals Quarterly report: Q3 2024

Nov 12, 2024, 4:30 PM EST - 1 year ago

Eton Pharmaceuticals Quarterly report: Q3 2024


Eton Pharmaceuticals Earnings release: Q3 2024

Nov 12, 2024, 4:30 PM EST - 1 year ago

Eton Pharmaceuticals Earnings release: Q3 2024


Eton Pharmaceuticals Earnings Call Transcript: Q2 2024

Aug 8, 2024, 4:30 PM EDT - 2 years ago

Eton Pharmaceuticals Earnings Call Transcript: Q2 2024


Eton Pharmaceuticals Quarterly report: Q2 2024

Aug 8, 2024, 4:30 PM EDT - 2 years ago

Eton Pharmaceuticals Quarterly report: Q2 2024


Eton Pharmaceuticals Earnings release: Q2 2024

Aug 8, 2024, 4:30 PM EDT - 2 years ago

Eton Pharmaceuticals Earnings release: Q2 2024


Eton Pharmaceuticals Earnings Call Transcript: Q1 2024

May 9, 2024, 4:30 PM EDT - 2 years ago

Eton Pharmaceuticals Earnings Call Transcript: Q1 2024


Eton Pharmaceuticals Quarterly report: Q1 2024

May 9, 2024, 4:30 PM EDT - 2 years ago

Eton Pharmaceuticals Quarterly report: Q1 2024


Eton Pharmaceuticals Earnings release: Q1 2024

May 9, 2024, 4:30 PM EDT - 2 years ago

Eton Pharmaceuticals Earnings release: Q1 2024


oaksapollo
oaksapollo Jul. 30 at 3:30 PM
$ETON what happened to $50?! I saw it briefly yesterday. Honestly, if it goes over $50 and stays there, I may be cashing in. My cost is $3.85. $50 is just too good to pass up.
2 · Reply
Tom2772
Tom2772 Jul. 30 at 7:52 AM
$GOSS $ETON $OTLK Thanks for sharing your thoughts. Just a quick fact check: Opaleye's 5.1% stake (13G) and the planned NDA submission are confirmed. The reverse split, $175M raise, 500M new shares, 30% dilution and a November exit are all speculation at this point, not company guidance.
0 · Reply
prat1703
prat1703 Jul. 30 at 7:19 AM
$GOSS : Few things I’d say, 1: GOSS has been noticed by the momentum pump and dump buyers (they’ll be gone by next week likely) 2. GOSS getting new investors, Opaleye opened a 5% position on July 22 (13 GA filing), they’re good ones, bought $ETON at $5 and kept it on their portfolio, and more importantly, are HODLERS, can see them holding through PFUFA easily 3. GOSS, we, everyone needs the RS (needs to be on NASDAQ Global Select), but more importantly, Options market open up as bid price >$2 (1:20 maybe my bet so $4) 4. Dilution is real and will happen, let’s say they add $175M to balance sheet and issue 500M more shares, then we all lose 30% easy, but here it’s important to keep some cash and buy more 5. November is the earliest possible exit horizon, if acceptance to file goes well, key de risking event will be gone and it’ll be the $OTLK moment, unless you’re aiming to hold for 12 months
3 · Reply
CharlieeMungerTWITS
CharlieeMungerTWITS Jul. 29 at 11:19 PM
$CORT geniuses whomever held this from $35.00 Same geniuses at $ETON Now do we have geniuses at $CELC after fda approval?
0 · Reply
pickens1
pickens1 Jul. 29 at 7:07 PM
0 · Reply
CharlieeMungerTWITS
CharlieeMungerTWITS Jul. 29 at 1:58 PM
0 · Reply
maniha
maniha Jul. 29 at 12:22 AM
$ETON it’s almost time…
0 · Reply
topstockalerts
topstockalerts Jul. 28 at 11:15 PM
$ETON that was a sharp rejection of lower prices.
0 · Reply
ScanStock
ScanStock Jul. 28 at 11:01 PM
Big bulls calling you APUS right now for a run! Looks like they might be right, Loads of bulls moving to APUS now! The next low float stock to squeeze north Look APUS starting to run with fresh news <-- $JBLU $FMAO $ETON $LPSN <<< -
0 · Reply
JFais
JFais Jul. 28 at 9:26 PM
What ticker comes to mind that you could've handled better? I owned $ETON at $3 to $4, but failed to hold patiently (now $47)
3 · Reply
oaksapollo
oaksapollo Jul. 28 at 8:03 PM
$ETON This is insane, I am officially up 10X. Not selling!
0 · Reply
CharlieeMungerTWITS
CharlieeMungerTWITS Jul. 28 at 6:05 PM
$ETON $46!!!! This is what happens after several months of fda approval. $18 on approval and now slow grind to heaven Sit tight $CELC
0 · Reply
StocktwitsNews
StocktwitsNews Jul. 28 at 4:46 PM
ETON Stock Jumps 10%: Why Does This Analyst See 47% Upside To Stock? $ETON $IWM $VTI https://stocktwits.com/news/equity/markets/eton-stock-jumps-10-why-does-this-analyst-see-47-upside-to-stock/cZZCM2nRJbW
0 · Reply
WAJeff
WAJeff Jul. 28 at 3:51 PM
$ETON 7/22 43.43s sold 46. Trying to not overstay my welcome in these runners
1 · Reply
Biorocksme
Biorocksme Jul. 25 at 6:37 PM
$ETON Stock nice rally (from$26) since cfo Matthews left the busted $ITRM To the liquidation ashes.
1 · Reply
CFontina
CFontina Jul. 25 at 5:37 PM
$ETON $HROW in two weeks, eton up 14% and hrow down 10%. A couple more days like this and the market caps will cross too . What an embarrassment for hrow.
1 · Reply
bryantboy99
bryantboy99 Jul. 24 at 9:20 PM
$ETON @CharlieeMungerTWITS been a good ride.
0 · Reply
CharlieeMungerTWITS
CharlieeMungerTWITS Jul. 24 at 12:51 PM
$ETON when you know you know
0 · Reply
CharlieeMungerTWITS
CharlieeMungerTWITS Jul. 24 at 11:07 AM
$ETON this is exactly how fda approval should go. Initial pump. Fade. Impatient forget and circle back 7 months later to 150% gains
0 · Reply
AMP19
AMP19 Jul. 23 at 5:52 PM
$ETON if this keeps steady climbing on market down days, 50$ seems inevitable in near future.
0 · Reply
CharlieeMungerTWITS
CharlieeMungerTWITS Jul. 23 at 2:25 PM
$ETON slow and steady in beast mode
0 · Reply